Khan KA, Naylor AJ, Khan A, Noy PJ, Mambretti M, Lodhia P, Athwal J, Korzystka A, Buckley CD, Willcox BE, Mohammed F and Bicknell R. (2017) Multimerin-2 is a ligand for group 14 family C-type lectins CLEC14A, CD93 and CD248 spanning the endothelial pericyte interface. Oncogene, E-pub Jul 3.
Wragg JW, Heath VL and Bicknell R. (2017) Sunitinib treatment enhances metastasis of innately drug-resistant breast tumors. Cancer Res. 77(4):1008-1020
Ferguson HJ, Wragg JW, Ward S, Heath VL, Ismail T and Bicknell R. (2016) Glutamate dependent NMDA receptor 2D is a novel angiogenic tumour endothelial marker in colorectal cancer. Oncotarget. 7(15):20440-54
Noy PJ, Swain RK, Khan K, Lodhia P and Bicknell R. (2016) Sprouting angiogenesis is regulated by shedding of the C-type lectin family 14, member A (CLEC14A) ectodomain, catalyzed by rhomboid-like 2 protein (RHBDL2). FASEB J. 30(6):2311-23.
Wragg JW, Finnity JP, Anderson JA, Ferguson HJ, Porfiri E, Bhatt RI, Murray PG, Heath VL and Bicknell R. (2016) MCAM and LAMA4 are highly enriched in tumor blood vessels of renal cell carcinoma and predict patient outcome. Cancer Res. 76(8):2314-26.
Noy PJ, Lodhia P, Khan K, Zhuang X, Ward DG, Verissimo AR, Bacon A and Bicknell R. (2015) Blocking CLEC14A-MMRN2 binding inhibits sprouting angiogenesis and tumour growth. Oncogene. 34(47):5821-31
Zhuang X, Herbert JM, Lodhia P, Bradford J, Turner AM, Newby PM, Thickett D, Naidu U, Blakey D, Barry S, Cross DA and Bicknell R. (2015) Identification of novel vascular targets in lung cancer. Br J Cancer. 112(3):485-94
Zhuang X, Ahmed F, Zhang Y, Ferguson HJ, Steele JC, Steven NM, Nagy Z, Heath VL, Toellner KM and Bicknell R. (2015) Robo4 vaccines induce antibodies that retard tumor growth. Angiogenesis. 18(1):83-95
Mura M, Swain RK, Zhuang X, Vorschmitt H, Reynolds G, Durant S, Beesley JF, Herbert JM, Sheldon H, Andre M, Sanderson S, Glen K, Luu NT, McGettrick HM, Antczak P, Falciani F, Nash GB, Nagy ZS and Bicknell R. (2012) Identification and angiogenic role of the novel tumor endothelial marker CLEC14A. Oncogene. 31(3):293-305